ORGANOGENESIS HOLDINGS INC. Retained Earnings
ORGANOGENESIS HOLDINGS INC. (ORGO) had Retained Earnings of -$152.50 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$152.50M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$56.23M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$3.08M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$46.78M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$152.50M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$56.23M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | -$3.08M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$46.78M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | -$68.34M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | -$58.95M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | -$40.11M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$47.78M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$60.11M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | -$43.07M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | -$40.97M 10-K · filed 2025-02-27 | |
| 2023-09-30 | -$40.40M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$43.57M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | -$48.88M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | -$45.30M 10-K · filed 2024-02-29 | |
| 2022-09-30 | -$52.79M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | -$53.00M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | -$61.75M 10-K · filed 2023-03-01 | -$60.05M 10-Q · filed 2022-05-10 |
| 2021-12-31 | -$60.83M 10-K · filed 2023-03-01 | -$60.13M 10-K · filed 2022-03-01 |
| 2021-09-30 | -$111.83M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | -$120.13M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | -$140.82M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | -$155.03M 10-K · filed 2022-03-01 | -$153.06M 10-K · filed 2021-03-16 |
| 2020-09-30 | -$171.55M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | -$192.49M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | -$187.32M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | -$171.01M 10-K · filed 2021-03-16 | |
| 2019-09-30 | -$166.61M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | -$155.22M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | -$145.57M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | -$130.24M 10-K · filed 2020-03-09 | |
| 2018-09-30 | $2.83M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | -$2.11M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | -$2.46M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | -$65.41M 10-K · filed 2019-03-18 | -$2.33M 10-K · filed 2018-03-14 |
| 2017-09-30 | -$1.83M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $287.34K 10-Q · filed 2017-08-11 | |
| 2017-03-31 | -$93.00K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | -$233.86K 10-K · filed 2018-03-14 | |
| 2016-09-30 | -$55.70K 10-Q · filed 2016-11-18 | |
| 2015-12-31 | -$25.16K 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |